Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37160667)

  • 1. Carborane-Based Tebufelone Analogs and Their Biological Evaluation In Vitro.
    Braun S; Paskaš S; Laube M; George S; Hofmann B; Lönnecke P; Steinhilber D; Pietzsch J; Mijatović S; Maksimović-Ivanić D; Hey-Hawkins E
    ChemMedChem; 2023 Jul; 18(14):e202300206. PubMed ID: 37160667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and In Vitro Biological Evaluation of
    Braun S; Jelača S; Laube M; George S; Hofmann B; Lönnecke P; Steinhilber D; Pietzsch J; Mijatović S; Maksimović-Ivanić D; Hey-Hawkins E
    Molecules; 2023 Jun; 28(11):. PubMed ID: 37299023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tebufelone (NE-11740), a new anti-inflammatory drug, on arachidonic acid metabolism.
    Weisman SM; Doyle MJ; Wehmeyer KR; Hynd BA; Eichhold TH; Clear RM; Coggeshall CW; Kuhlenbeck DL
    Agents Actions; 1994 May; 41(3-4):156-63. PubMed ID: 7942323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carborane Analogues of Fenoprofen Exhibit Improved Antitumor Activity.
    Useini L; Mojić M; Laube M; Lönnecke P; Mijatović S; Maksimović-Ivanić D; Pietzsch J; Hey-Hawkins E
    ChemMedChem; 2023 Mar; 18(5):e202200583. PubMed ID: 36583943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of transthyretin amyloidosis inhibitors containing carborane pharmacophores.
    Julius RL; Farha OK; Chiang J; Perry LJ; Hawthorne MF
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):4808-13. PubMed ID: 17360344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription, translation and secretion of interleukin 1 and tumor necrosis factor: effects of tebufelone, a dual cyclooxygenase/5-lipoxygenase inhibitor.
    Sirko SP; Schindler R; Doyle MJ; Weisman SM; Dinarello CA
    Eur J Immunol; 1991 Feb; 21(2):243-50. PubMed ID: 1847874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption, bioavailability, and pharmacokinetics of tebufelone in the rat.
    Sietsema WK; Kelm GR; Deibel RM; Doyle MJ; Loomans ME; Smyth RE; Kinnett GO; Eichhold TH; Farmer RW
    J Pharm Sci; 1993 Jun; 82(6):610-2. PubMed ID: 8331535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR study of dual cyclooxygenase and 5-lipoxygenase inhibitors 2,6-di-tert-butylphenol derivatives.
    Ruiz J; Pérez C; Pouplana R
    Bioorg Med Chem; 2003 Sep; 11(19):4207-16. PubMed ID: 12951151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel di-tertiary-butyl phenylhydrazones as dual cyclooxygenase-2/5-lipoxygenase inhibitors: synthesis, COX/LOX inhibition, molecular modeling, and insights into their cytotoxicities.
    Ghatak S; Vyas A; Misra S; O'Brien P; Zambre A; Fresco VM; Markwald RR; Swamy KV; Afrasiabi Z; Choudhury A; Khetmalas M; Padhye S
    Bioorg Med Chem Lett; 2014 Jan; 24(1):317-24. PubMed ID: 24295787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipyretic activity of tebufelone (NE-11740) in man.
    Powell JH; Meredith MP; Vargas R; McMahon FG; Jain AK
    Agents Actions Suppl; 1991; 32():45-9. PubMed ID: 2069096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carborane-Based Analogues of 5-Lipoxygenase Inhibitors Co-inhibit Heat Shock Protein 90 in HCT116 Cells.
    Kuhnert R; Sárosi MB; George S; Lönnecke P; Hofmann B; Steinhilber D; Steinmann S; Schneider-Stock R; Murganić B; Mijatović S; Maksimović-Ivanić D; Hey-Hawkins E
    ChemMedChem; 2019 Jan; 14(2):255-261. PubMed ID: 30471171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the effects of tebufelone on hepatic cytochromes P450 in the beagle dog.
    Smith BJ; Zupan LA; Hu JK; Diters RW; Gibson GW; Norton JN
    Drug Metab Dispos; 1996 May; 24(5):523-8. PubMed ID: 8723731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New cyclooxygenase-2/5-lipoxygenase inhibitors. 1. 7-tert-buty1-2,3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: discovery and variation of the 5-keto substituent.
    Janusz JM; Young PA; Ridgeway JM; Scherz MW; Enzweiler K; Wu LI; Gan L; Darolia R; Matthews RS; Hennes D; Kellstein DE; Green SA; Tulich JL; Rosario-Jansen T; Magrisso IJ; Wehmeyer KR; Kuhlenbeck DL; Eichhold TH; Dobson RL; Sirko SP; Farmer RW
    J Med Chem; 1998 Mar; 41(7):1112-23. PubMed ID: 9544211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs).
    Tai HH; Chi X; Tong M
    Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):37-40. PubMed ID: 21763448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboranyl Analogues of Celecoxib with Potent Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines.
    Buzharevski A; Paskas S; Sárosi MB; Laube M; Lönnecke P; Neumann W; Mijatovic S; Maksimovic-Ivanic D; Pietzsch J; Hey-Hawkins E
    ChemMedChem; 2019 Feb; 14(3):315-321. PubMed ID: 30602073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel dual cyclooxygenase and lipoxygenase inhibitors targeting hyaluronan-CD44v6 pathway and inducing cytotoxicity in colon cancer cells.
    Misra S; Ghatak S; Patil N; Dandawate P; Ambike V; Adsule S; Unni D; Venkateswara Swamy K; Padhye S
    Bioorg Med Chem; 2013 May; 21(9):2551-9. PubMed ID: 23517721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covalent modification of cyclooxygenase-2 (COX-2) by 2-acetoxyphenyl alkyl sulfides, a new class of selective COX-2 inactivators.
    Kalgutkar AS; Kozak KR; Crews BC; Hochgesang GP; Marnett LJ
    J Med Chem; 1998 Nov; 41(24):4800-18. PubMed ID: 9822550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity.
    Shrivastava SK; Srivastava P; Bandresh R; Tripathi PN; Tripathi A
    Bioorg Med Chem; 2017 Aug; 25(16):4424-4432. PubMed ID: 28669741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of corticosterone in modulation of eicosanoid biosynthesis and antiinflammatory activity by 5-lipoxygenase (5-LO) and cyclooxygenase (CO) inhibitors.
    Tomchek LA; Hartman DA; Lewin AC; Calhoun W; Chau TT; Carlson RP
    Agents Actions; 1991 Sep; 34(1-2):20-4. PubMed ID: 1665293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies.
    Migliore M; Habrant D; Sasso O; Albani C; Bertozzi SM; Armirotti A; Piomelli D; Scarpelli R
    Eur J Med Chem; 2016 Feb; 109():216-37. PubMed ID: 26774927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.